1)Desloratadine Tablets地氯雷他定片
2)Loratadine氯雷他定片
1.Efficacy and Safety of Mizolastine Sustained Release Tablets Comparison with Loratadine Tablets in Patients with Urticaria;目的比较咪唑斯汀缓释片与氯雷他定片治疗荨麻疹的有效性与安全性。
3)desloratadine地氯雷他定
1.Influence of Desloratadine on Rat Enter-Mast Cells;地氯雷他定对慢性应激大鼠肠道肥大细胞的影响
2.Comparison of two methods to determine desloratadine concentration;地氯雷他定含量两种测定方法的比较
3.Treatment on Chronic Urticaria with Desloratadine Combined with Dipyridamole;地氯雷他定联合潘生丁治疗慢性荨麻疹疗效观察
英文短句/例句
1.Study of genotoxicity and teratogenicity of DSL地氯雷他定遗传毒性及致畸性实验研究
2.Fifty-six Cases of Curing Chronic Hives with the Help of Desloratadine;地氯雷他定治疗56例慢性荨麻疹疗效观察
3.Efficacy and Safety of Desloratadine in Chronic Urticaria:A Systematic Review地氯雷他定治疗慢性荨麻疹的系统评价
4.Conclusion Desloratadine is effective and safe in treating CIU patients.结论:地氯雷他定治疗慢性特发性荨麻疹安全有效。
5.Efficacy and Safety of Desloratadine Tablets and P - Transfer Factor for Oral in the Treatment of Chronic Urticaria地氯雷他定联合转移因子口服治疗慢性荨麻疹30例疗效观察
6.Clinical observation on 30 cases with dermographism treated with desloratadine and BCG Polysaccharide and nucleic acid preparation地氯雷他定联合斯奇康治疗皮肤划痕症30例临床观察
7.Synthesis and Characterization of Molecularly Imprinted Polymer of Desloratadine地氯雷他定的分子印迹聚合物的制备及其吸附性研究
8.Glycyrrhizin in combination of desloratadine in the treatment of chronic urticaria复方甘草甜素联合地氯雷他定分散片治疗慢性荨麻疹疗效观察
9.Treatment of autosensitization eczema with two methods咪唑斯汀与地氯雷他定治疗自身敏感性湿疹的比较
10.Investigation on the therapeutic effect of desloratadine combined immuned treatment in treatment of autoimmune urticaria地氯雷他定配合免疫疗法治疗自身免疫性荨麻疹疗效分析
11.Observation of curative effect of treatment to chronic urticaria by Fuyang Keli combined with Desloratadine tablets肤痒颗粒联合地氯雷他定治疗慢性荨麻疹的疗效观察
12.The Effect of Desloratadine on Levels of Interleukin-4, Thromboxane B2, Leukotrienes in Patients Suffering from Atopic Rhinitis;地氯雷他定对变应性鼻炎病人血清白介素4,血栓素B2和白三烯的影响研究
13.Conclusion: Both desloratadine and loratadine are well tolerated and effective in the treatment of CIU.结论:地洛他定治疗慢性特发性荨麻疹安全、有效,与氯雷他定相当。
14.GC/MS analysis method of research for loratadine氯雷他定的GC/MS分析方法研究
15.The Clinical Observation of Garidi Wuwei Wan and Loratadine on Chronic urticaria嘎日迪五味丸联合氯雷他定治疗慢性荨麻疹
16.Efficaey and safety of loratadine versus mizolastine on chronic urticaria氯雷他定、咪唑斯汀治疗慢性荨麻疹的疗效比较
17.A Multi-center Randomized Controlled Single-blinded Trail of Compound Loratadine Capsule and Loratadine Psudoephadrine Tablet for Allergic Rhinitis;复方氯雷他定缓释胶囊与氯雷伪麻缓释片多中心随机单盲对照临床研究
18.The Treatment of Chronic Urticaria of 96 Cases with BCG Polysaccharides Nucleic Acid and Loratadine in the Combination卡介菌多糖核酸联合氯雷他定治疗慢性荨麻疹96例
相关短句/例句
Loratadine氯雷他定片
1.Efficacy and Safety of Mizolastine Sustained Release Tablets Comparison with Loratadine Tablets in Patients with Urticaria;目的比较咪唑斯汀缓释片与氯雷他定片治疗荨麻疹的有效性与安全性。
3)desloratadine地氯雷他定
1.Influence of Desloratadine on Rat Enter-Mast Cells;地氯雷他定对慢性应激大鼠肠道肥大细胞的影响
2.Comparison of two methods to determine desloratadine concentration;地氯雷他定含量两种测定方法的比较
3.Treatment on Chronic Urticaria with Desloratadine Combined with Dipyridamole;地氯雷他定联合潘生丁治疗慢性荨麻疹疗效观察
4)Loratadine dispersible tablets氯雷他定分散片
1.The UV spectrophotometry for determination of Loratadine dispersible tablets has been developed.介绍了紫外分光光度法测定氯雷他定分散片的含量。
5)Desloratadine/anal地氯雷他定/分析
6)loratadine氯雷他定
1.Preparation and Quality Control of Loratadine Tablets;氯雷他定片的制备及质量控制
2.The observation about the curative effective of Fangfengtongsheng pill combining loratadine in the therapy of chronic urticaria;防风通圣丸联合氯雷他定治疗慢性荨麻疹疗效观察
延伸阅读
氯雷他定片药物名称:氯雷他定片英文名:Loratadine Tablets汉语拼音:主要成分:氯雷他定性状:白色片药理作用:氯雷他定为口服的长效三环类抗组胺药,起效快,作用强,为第三代抗组胺药,具有选择性的对抗外周H1受体的作用。 用豚鼠研究表明,作用时间为18~24小时,对中枢作用的研究表明,对小鼠、大鼠、狗和猴很少或没有抑制作用或抗胆碱能作用。药代动力学:人口服后迅速自胃肠道吸收,1小时后血药浓度达峰值,本品在体内广泛代谢,其主要代谢产物去羧乙氧氯雷他定具有很强的抗H1受体作用。本品和去羧乙氧氯雷他定的半衰期分别为12和18小时,本品与血浆蛋白的结合率为98%左右,去羧乙氧氯雷他定的结合率较低,本品及其他的代谢产物可在乳汁中检出,但通过血脑屏障的药量不多,本品及其代谢产物随尿和粪排出体外。适应症:用于缓解过敏性鼻炎有关的症状,如喷嚏、流涕及鼻痒、鼻塞以及眼部痒及烧灼感,口服药物后鼻和眼部症状及体征得以迅速缀解,亦适用于缓解慢性荨麻疹、瘙痒性皮肤病及其他过敏性皮肤病的症状及体征。用法与用量:成人:一次10mg,一天1次。2~12岁儿童:体重>30Kg,一次1mg,一天1次。体重≤30Kg,一次5mg,一天1次。不良反应:在临床对照试验中,氯雷他定未显示临床上明显的镇静或抗胆碱能作用,其发生率与安慰剂相似。乏力、头痛和恶心的报告很罕见。禁忌症:具有过敏反应或特异体质的病人禁用。注意事项: 1 2岁以下儿童服用氯雷他定的安全性及疗效目前尚未确定。 2 妊娠期应用氯雷他定的安全性未被确定,因此,仅在权衡利弊之后,对胎儿有利的情况下方能应用,因为氯雷他定可以从乳汁中分泌,并且抗组胺药对婴儿的危险性增大,特别是对新生儿和早产儿,所以必须决定是停止哺乳还是停止服药,氯雷他定应用于哺乳期妇女必须非常谨慎。 3 当与酒同时服用时;根据精神运动试验研究表明氯雷他定无药力相加作用。 4 在作皮试前的大约48小时应停止使用氯雷他定,因抗组胺药能消除或减轻皮肤对所用变应原的阳性反应。规格: 10mg贮藏:遮光,密闭保存。有效期:暂定4年。处方药:是
